Disease on EC 2.4.2.35 - flavonol-3-O-glycoside xylosyltransferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE 
TITLE OF PUBLICATION
LINK TO PUBMED
Chondrosarcoma
Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides.
Choriocarcinoma
High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase.
Essential Hypertension
Xylosyltransferase gene variants and their role in essential hypertension.
Joint Diseases
UDP-D-xylose: proteoglycan core protein beta-D-xylosyltransferase: a new marker of cartilage destruction in chronic joint diseases.
Leukemia
Glycosaminoglycan metabolism of HL-60 cells during differentiation induction by tetradecanoylphorbol-13-acetate.
Liver Cirrhosis
Increased serum xylosyltransferase activity in patients with liver fibrosis.
Lung Injury
Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat.
Melanoma
Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides.
Neoplasms
Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
Nervous System Diseases
Deoxyribozymes: new therapeutics to treat central nervous system disorders.
Proteinuria
[Gene expressions of xylosyltransferase and heparanase in renal tissue of rat with adriamycin nephropathy and relevance for proteinuria]
Pseudoxanthoma Elasticum
Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course.
Scleroderma, Diffuse
Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis.
Scleroderma, Systemic
Elevated serum xylosyltransferase activity correlates with a high level of hyaluronate in patients with systemic sclerosis.
Scleroderma, Systemic
Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis.
Spinal Cord Injuries
Deoxyribozymes: new therapeutics to treat central nervous system disorders.
Stomach Neoplasms
Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
html completed
